Key result
Frailty linked to ~232% greater 6-month mortality risk in MI patients.
Why the study?
Data on the prognostic value of frailty to guide clinical decision-making for patients with myocardial infarction are scarce.
Is frailty associated with increased 6-month mortality in patients after acute myocardial infarction?
Observational (n=3,381)
Yes
Is frailty associated with increased 6-month mortality in patients after acute myocardial infarction?
Frailty assessed by the Clinical Frailty Scale is strongly and independently associated with 6-month mortality in patients after acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
Supports frailty screening post-MI for prognostication; leaves open whether interventions targeting frailty improve outcomes.
AIMS: Data on the prognostic value of frailty to guide clinical decision-making for patients with myocardial infarction (MI) are scarce. To analyse the association between frailty classification, treatment patterns, in-hospital outcomes, and 6-month mortality in a large population of patients with MI. METHODS AND RESULTS: An observational, multicentre study with a retrospective analysis of prospectively collected data using the SWEDEHEART registry. In total, 3381 MI patients with a level of frailty assessed using the Clinical Frailty Scale (CFS-9) were included. Of these patients, 2509 (74.2%) were classified as non-vulnerable non-frail (CFS 1-3), 446 (13.2%) were vulnerable non-frail (CFS 4), and 426 (12.6%) were frail (CFS 5-9). Frailty and non-frail vulnerability were associated with worse in-hospital outcomes compared with non-frailty, i.e. higher rates of mortality (13.4% vs. 4.0% vs. 1.8%), cardiogenic shock (4.7% vs. 2.5% vs. 1.9%), and major bleeding (4.5% vs. 2.7% vs. 1.1%) (all P < 0.001), and less frequent use of evidence-based therapies. In Cox regression analyses, frailty was strongly and independently associated with 6-month mortality compared with non-frailty, after adjustment for age, sex, the GRACE risk score components, and other potential risk factors [hazard ratio (HR) 3.32, 95% confidence interval (CI) 2.30-4.79]. A similar pattern was seen for vulnerable non-frail patients (fully adjusted HR 2.07, 95% CI 1.41-3.02). CONCLUSION: Frailty assessed with the CFS was independently and strongly associated with all-cause 6-month mortality, also after comprehensive adjustment for baseline differences in other risk factors. Similarly, non-frail vulnerability was independently associated with higher mortality compared with those with preserved functional ability.
No takes yet. Share an insight, caveat, or question.
Ekerstad et al. (2021) conducted an observational in myocardial infarction (n=3,381). Frailty (CFS 5-9) vs. Non-frailty (CFS 1-3) was evaluated on 6-month mortality (HR 3.32, 95% CI 2.30-4.79). Frailty was independently associated with a higher risk of 6-month mortality compared with non-frailty in patients with myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: